Watch Ticker

Entero Therapeutics, Inc. Common Stock

Go to Entero Therapeutics, Inc. Common Stock Website

$0.41

-0.01 (-2.89%)

Live

Previous Close

$0.4251

Day Range

$0.4068 - $0.447499

Previous Day Range

$0.4147 - $0.46

Market Cap

$2.0 million USD

Day Vol.

22507

Previous Day Vol.

38519

Currency

USD

Primary Exchange

None

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglu...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Entero Therapeutics Appoints Richard Paolone as CEO

Entero Therapeutics, a clinical-stage biopharmaceutical company, has appointed Richard Paolone as the interim CEO. Paolone is a Toronto-based securities lawyer with extensive experience in corporate finance, securities law, and mergers and acquisitions.

Related tickers: ENTO.

Read Full Article

Monteverde & Associates Pc - $HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of SUM, ENTO, ALVR and STAF

The M&A Class Action Firm is investigating the proposed mergers of Summit Materials, Entero Therapeutics, AlloVir, and Staffing 360 Solutions, providing details on the terms of each merger and encouraging shareholders to contact the firm for more information.

Related tickers: SUM, ENTO, ALVR, STAF.

Read Full Article

Trending Tickers

Please sign in to view